Prostate volume index stratified prostate cancer risk in patients elected to a first random biopsy set
- PMID: 28291903
- DOI: 10.5301/tj.5000607
Prostate volume index stratified prostate cancer risk in patients elected to a first random biopsy set
Abstract
Objective: To investigate prostate volume index (PVI), defined as the ratio of volume of the transitional zone on that of the peripheral zone, as a factor stratifying prostate cancer (PCA) risk in patients elected to a first random biopsy set.
Methods: The study evaluated 596 patients who were elected to a first random biopsy set because of suspected PCA in a period between September 2010 and September 2015. Prostate volume index was dichotomized to PVI ≤1 vs PVI >1. The multivariate logistic regression model investigated clinical factors with dichotomized PVI associating with PCA.
Results: The detection rate of PCA was 49%. The dichotomized PVI >1 stratified PCA risk (odds ratio [OR] 0.455; p<0.0001) beyond age (OR 1.062; p<0.0001), PSA (OR 1.167; p<0.0001), PV (OR 0.957; p<0.0001), and abnormal digital rectal examination (OR 2.094; p<0.0001). The goodness of fit statistics assessed model efficacy.
Conclusions: A large cohort of patients elected to a first random biopsy set had PCA risk stratified by dichotomized PVI beyond other clinical independent factors. Confirmatory studies are required.
Similar articles
-
Prostate Volume Index Associates with a Decreased Risk of Prostate Cancer: Results of a Large Cohort of Patients Elected to a First Biopsy Set.Urol Int. 2017;98(1):22-27. doi: 10.1159/000447432. Epub 2016 Jul 5. Urol Int. 2017. PMID: 27376763
-
Intraprostatic chronic inflammation is associated with a reduced risk of prostate cancer in patients elected to a first random biopsy set.Tumori. 2017 Sep 18;103(5):475-482. doi: 10.5301/tj.5000573. Epub 2016 Nov 9. Tumori. 2017. PMID: 27834470
-
Prostate Volume Index Is Able to Differentiate between Prostatic Chronic Inflammation and Prostate Cancer in Patients with Normal Digital Rectal Examination and Prostate-Specific Antigen Values <10 ng/mL: Results of 564 Biopsy Naïve Cases.Urol Int. 2019;103(4):415-422. doi: 10.1159/000502659. Epub 2019 Aug 29. Urol Int. 2019. PMID: 31466070
-
Should men with serum prostate-specific antigen < or =4 ng/ml and normal digital rectal examination undergo a prostate biopsy? A literature review.Oncology. 2006;70(2):81-9. doi: 10.1159/000092583. Epub 2006 Apr 4. Oncology. 2006. PMID: 16601365 Review.
-
[Progress in the studies of prostate biopsy methods].Zhonghua Nan Ke Xue. 2022 Feb;28(2):167-172. Zhonghua Nan Ke Xue. 2022. PMID: 37462491 Review. Chinese.
Cited by
-
Prostatic chronic inflammation and prostate cancer risk at baseline random biopsy: Analysis of predictors.Arab J Urol. 2020 May 13;18(3):148-154. doi: 10.1080/2090598X.2020.1757335. Arab J Urol. 2020. PMID: 33029424 Free PMC article.
-
Prostate volume index and prostatic chronic inflammation predicted low tumor load in 945 patients at baseline prostate biopsy.World J Urol. 2020 Apr;38(4):957-964. doi: 10.1007/s00345-019-02830-7. Epub 2019 Jun 1. World J Urol. 2020. PMID: 31154465
-
Prostate volume index and prostatic chronic inflammation have an effect on tumor load at baseline random biopsies in patients with normal DRE and PSA values less than 10 ng/ml: results of 564 consecutive cases.Ther Adv Urol. 2019 Aug 14;11:1756287219868604. doi: 10.1177/1756287219868604. eCollection 2019 Jan-Dec. Ther Adv Urol. 2019. PMID: 31452688 Free PMC article.
-
Elevated prostate volume index and prostatic chronic inflammation reduce the number of positive cores at first prostate biopsy set: results in 945 consecutive patients.Int Braz J Urol. 2020 Jul-Aug;46(4):545-556. doi: 10.1590/S1677-5538.IBJU.2019.0146. Int Braz J Urol. 2020. PMID: 32213210 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous